Objective: Complete resectability of all visualized tumor
implants at debulking surgery for advanced epithelial ovarian cancer is
confirmed to be the single most important prognostic factor. This study
aimsto develop preoperative predicting score based on clinical, biological, and radiological criteria of
epithelial ovarian cancer to assess the feasibility of complete cytoreduction. Study
Design: A retrospective record-based study. Patients and Methods: The
study was conducted upon 50 consecutive patients managed for epithelial ovarian
cancer with FIGO stage III. Patients’ data were collected from records of the
Gyne-Oncology Clinic of El Shatby University Maternity Hospital affiliated to Alexandria University. Results:Many parameters were significantly associated with completeness of
resectability in univariate analysis; including age, BMI, CA125, albumin,
pre-albumin, PCI, mesenteric, and right copula of diaphragm affection by CT
scan (p value < 0.05). A 100-point
predictability score was developed, 10 for BMI ≥35 kg/m2, 25 points for Pre albumin < 14.5 mg/dl, 35 points for
mesenteric
References
[1]
Torre, L., Bray, F., Siegel, R., Ferlay, J., Lortet-Tieulent, J. and Jemal, A. (2015) Global Cancer Statistics, 2012. CA: A Cancer Journal for Clinicians, 65, 87-108.
https://doi.org/10.3322/caac.21262
[2]
Aure, J., Hoeg, K. and Kolstad, P. (1971) Clinical and Histologic Studies of Ovarian Carcinoma: Long-Term Follow-up of 990 Cases. Obstetrics and Gynecology, 37, 470-472. https://doi.org/10.1097/00006254-197106000-00022
[3]
Coleman, M., Forman, D., Bryant, H., Butler, J., Rachet, B., Maringe, C., et al. (2011) Cancer Survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (The International Cancer Benchmarking Partnership): An Analysis of Population-Based Cancer Registry Data. The Lancet, 377, 127-138.
https://doi.org/10.1016/S0140-6736(10)62231-3
[4]
Vergote, I., Tropé, C., Amant, F., Kristensen, G., Ehlen, T., Johnson, N., et al. (2010) Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer. New England Journal of Medicine, 363, 943-953.
https://doi.org/10.1056/NEJMoa0908806
[5]
Feng, Z., Wen, H., Jiang, Z., Liu, S., Ju, X., Chen, X., et al. (2018) A Triage Strategy in Advanced Ovarian Cancer Management Based on Multiple Predictive Models for R0 Resection: A Prospective Cohort Study. Journal of Gynecologic Oncology, 29, Article No. e65. https://doi.org/10.3802/jgo.2018.29.e65
[6]
Bois, A., Reuss, A., Pujade-Lauraine, E., Harter, P., Ray-Coquard, I. and Pfisterer, J. (2009) Role of Surgical Outcome as Prognostic Factor in Advanced Epithelial Ovarian Cancer: A Combined Exploratory Analysis of 3 Prospectively Randomized Phase 3 Multicenter Trials. Cancer, 115, 1234-1244.
https://doi.org/10.1002/cncr.24149
[7]
Bristow, R., Tomacruz, R., Armstrong, D., Trimble, E. and Montz, F. (2002) Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma during the Platinum Era: A Meta-Analysis. Journal of Clinical Oncology, 20, 1248-1259.
https://doi.org/10.1200/JCO.2002.20.5.1248
[8]
Chi, D., Eisenhauer, E., Lang, J., Huh, J., Haddad, L., Abu-Rustum, N., et al. (2006) What Is the Optimal Goal of Primary Cytoreductive Surgery for Bulky Stage IIIC Epithelial Ovarian Carcinoma (EOC)? Gynecologic Oncology, 103, 559-564.
https://doi.org/10.1016/j.ygyno.2006.03.051
[9]
Rutten, M., Sonke, G., Westermann, A., van Driel, W., Trum, J., Kenter, G., et al. (2015) Prognostic Value of Residual Disease after Interval Debulking Surgery for FIGO Stage IIIC and IV Epithelial Ovarian Cancer. Obstetrics and Gynecology International, 2015, Article ID: 464123. https://doi.org/10.1155/2015/464123
[10]
Fagotti, A., Ferrandina, G., Fanfani, F., Ercoli, A., Lorusso, D., Rossi, M., et al. (2006) A Laparoscopy-Based Score to Predict Surgical Outcome in Patients with Advanced Ovarian Carcinoma: A Pilot Study. Annals of Surgical Oncology, 3, 1156-1161.
https://doi.org/10.1245/ASO.2006.08.021
[11]
Brun, J., Rouzier, R., Uzan, S. and Daraï, E. (2008) External Validation of a Laparoscopic-Based Score to Evaluate Resectability of Advanced Ovarian Cancers: Clues for a Simplified Score. Gynecologic Oncology, 110, 354-359.
https://doi.org/10.1016/j.ygyno.2008.04.042
[12]
Rutten, M., Van Meurs, H., Van De Vrie, R., Naaktgeboren, C., Fons, G., Opmeer, B., et al. (2017) Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients with Advanced Ovarian Cancer: A Randomized Controlled Trial. Journal of Clinical Oncology, 35, 613-621. https://doi.org/10.1200/JCO.2016.69.2962
[13]
Gómez-Hidalgo, N., Martinez-Cannon, B., Nick, A., Lu, K., Sood, A., Coleman, R., et al. (2015) Predictors of Optimal Cytoreduction in Patients with Newly Diagnosed Advanced-Stage Epithelial Ovarian Cancer: Time to Incorporate Laparoscopic Assessment into the Standard of Care. Gynecologic Oncology, 137, 553-558.
https://doi.org/10.1016/j.ygyno.2015.03.049
[14]
Lee, C.L., Kay, N., Chen, H.L., Yen, C.F. and Huang, K.G. (2009) The Roles of Laparoscopy in Treating Ovarian Cancer. Taiwanese Journal of Obstetrics and Gynecology, 48, 9-14. https://doi.org/10.1016/S1028-4559(09)60029-2
[15]
Rutten, M., Leeflang, M., Kenter, G., Mol, B. and Buist, M. (2014) Laparoscopy for Diagnosing Resectability of Disease in Patients with Advanced Ovarian Cancer. Cochrane Database of Systematic Reviews, No. 2, Article No. CD009786.
https://doi.org/10.1002/14651858.CD009786.pub2
[16]
Chesnais, M., Lecuru, F., Mimouni, M., Ngo, C., Fauconnier, A. and Huchon, C. (2017) A Pre-Operative Predictive Score to Evaluate the Feasibility of Complete Cytoreductive Surgery in Patients with Epithelial Ovarian Cancer. PLoS ONE, 12, e0187245. https://doi.org/10.1371/journal.pone.0187245
[17]
Geisler, J., Linnemeier, G., Thomas, A. and Manahan, K. (2017) Nutritional Assessment Using Prealbumin as an Objective Criterion to Determine Whom Should Not Undergo Primary Radical Cytoreductive Surgery for Ovarian Cancer. Gynecologic Oncology, 106, 128-131. https://doi.org/10.1016/j.ygyno.2007.03.008
[18]
Memarzadeh, S., Lee, S., Berek, J. and Farias-Eisner, R.P. (2003) CA125 Levels Are a Weak Predictor of Optimal Cytoreductive Surgery in Patients with Advanced Epithelial Ovarian Cancer. International Journal of Gynecologic Cancer, 13, 120-124.
https://doi.org/10.1136/ijgc-00009577-200303000-00003
[19]
Rosendahl, M., Harter, P., Bjørn, S. and Høgdall, C. (2018) Specific Regions, Rather than the Entire Peritoneal Carcinosis Index, Are Predictive of Complete Resection and Survival in Advanced Epithelial Ovarian Cancer. International Journal of Gynecologic Cancer, 28, 316-322. https://doi.org/10.1097/IGC.0000000000001173
[20]
Dessapt, A., Huchon, C., Ngo, C., Bats, A., Bensaid, C. and Lecuru, F. (2016) Is Complete Cytoreductive Surgery Feasible in This Patient with Ovarian Cancer? Surgical Oncology, 25, 326-331. https://doi.org/10.1016/j.suronc.2016.07.001
